ATE390434T1 - Inositolphosphoglycanderivate und ihre medizinische verwendung - Google Patents

Inositolphosphoglycanderivate und ihre medizinische verwendung

Info

Publication number: ATE390434T1
Authority: AT; Austria
Prior art keywords: inositol; phosphoglycand; derivatives; compounds; medical use
Prior art date: 2000-05-12

Application number

AT01928115T

Other languages

English (en)

Inventor

Thomas Rademacher

Hugo Caro

Irene Francois

Manuel Martin-Lomas

Original Assignee

Rodaris Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-12

Filing date

2001-05-11

Publication date

2008-04-15

2000-05-12 Priority claimed from GB0011593A external-priority patent/GB0011593D0/en

2001-03-02 Priority claimed from US09/798,004 external-priority patent/US6716826B2/en

2001-05-11 Application filed by Rodaris Pharmaceuticals Ltd filed Critical Rodaris Pharmaceuticals Ltd

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE390434T1 publication Critical patent/ATE390434T1/de

Links

CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title abstract 2
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 title 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
229960000367 inositol Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 4
150000003999 cyclitols Chemical class 0.000 abstract 2
230000001668 ameliorated effect Effects 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Materials For Medical Uses (AREA)

AT01928115T 2000-05-12 2001-05-11 Inositolphosphoglycanderivate und ihre medizinische verwendung ATE390434T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20359800P	2000-05-12	2000-05-12
GB0011593A GB0011593D0 (en)	2000-05-12	2000-05-12	Compounds and their uses
US09/798,004 US6716826B2 (en)	2000-05-12	2001-03-02	Compounds and their uses

Publications (1)

Publication Number	Publication Date
ATE390434T1 true ATE390434T1 (de)	2008-04-15

Family

ID=27255716

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01928115T ATE390434T1 (de)	2000-05-12	2001-05-11	Inositolphosphoglycanderivate und ihre medizinische verwendung

Country Status (6)

Country	Link
EP (1)	EP1409498B1 (de)
AT (1)	ATE390434T1 (de)
AU (1)	AU2001254979A1 (de)
CA (1)	CA2433857C (de)
DE (1)	DE60133421D1 (de)
WO (1)	WO2001085745A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003248927A1 (en) *	2002-07-10	2004-01-23	Massachusetts Institute Of Technology	Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
EP3219304A4 (de) *	2014-11-10	2018-05-16	Showa Denko K.K.	Befeuchtungsmittel

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0649715B2 (ja) *	1987-02-10	1994-06-29	栗田工業株式会社	末端にイノシト−ル残基を結合したグルコオリゴ糖およびその製造方法
JPH03237101A (ja) *	1989-12-18	1991-10-23	Rikagaku Kenkyusho	グリコシルフォスファチジルイノシトールアンカー合成中間体及びグリコシルフォスファチジルイノシトールアンカー類縁体の合成中間体
JPH04120089A (ja) *	1990-09-11	1992-04-21	Rikagaku Kenkyusho	グリコシルフォスファチジルイノシトールアンカー合成中間体
JPH06293790A (ja) *	1993-04-08	1994-10-21	Kyowa Hakko Kogyo Co Ltd	生理活性物質イノシトールグリカン
GB9618931D0 (en) *	1996-09-11	1996-10-23	Univ London	Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
DE19649350A1 (de) *	1996-11-28	1998-06-04	Hoechst Ag	Inositolglykane mit insulinartiger Wirkung
CA2236641C (en) *	1997-05-07	2008-07-15	Cornell Research Foundation, Inc.	Preparation of fagopyritols and uses therefor
GB9801899D0 (en) *	1998-01-29	1998-03-25	Univ London	Neurotrophic properties of ipgs analogues
AUPP589398A0 (en) *	1998-09-14	1998-10-08	Walter And Eliza Hall Institute Of Medical Research, The	Immunogenic compositions and uses thereof

2001
- 2001-05-11 AT AT01928115T patent/ATE390434T1/de not_active IP Right Cessation
- 2001-05-11 CA CA2433857A patent/CA2433857C/en not_active Expired - Fee Related
- 2001-05-11 DE DE60133421T patent/DE60133421D1/de not_active Expired - Lifetime
- 2001-05-11 AU AU2001254979A patent/AU2001254979A1/en not_active Abandoned
- 2001-05-11 EP EP01928115A patent/EP1409498B1/de not_active Expired - Lifetime
- 2001-05-11 WO PCT/GB2001/002098 patent/WO2001085745A1/en not_active Ceased

Also Published As

Publication number	Publication date
DE60133421D1 (de)	2008-05-08
CA2433857A1 (en)	2001-11-15
WO2001085745A1 (en)	2001-11-15
EP1409498B1 (de)	2008-03-26
AU2001254979A1 (en)	2001-11-20
EP1409498A1 (de)	2004-04-21
CA2433857C (en)	2012-07-31

Similar Documents

Publication	Publication Date	Title
BR9911621A (pt)	2001-10-16	Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina
WO2002072570A3 (en)	2003-03-06	Non-imidazole compounds as histamine h3 antagonists
BRPI0514661B8 (pt)	2021-05-25	antagonistas de vasopressina v1a, composição farmacêutica e uso dos referidos antagonistas
UY28766A1 (es)	2005-08-31	Compuestos heteropolicíclicos adicionales y su uso como antagonistas del receptor de glutamato metabotrópico
FR2838439B1 (fr)	2005-05-20	Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
MXPA05008524A (es)	2005-10-20	Pirazoles y metodos de elaboracion y uso de los mismos.
DK1187918T4 (da)	2009-02-23	TEK-antagonister
MXPA05002442A (es)	2005-09-30	Imidazolopiridinas y metodos para la elaboracion y uso de las mismas.
DE69616480D1 (de)	2001-12-06	Piperidinderivate als neurokininantagonisten
WO2005000820A3 (fr)	2005-03-17	Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
WO2006044362A3 (en)	2006-12-07	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
PA8556701A1 (es)	2003-07-28	Derivados del 3-azabiciclo(3.1.0)hexano
DE602004018637D1 (de)	2009-02-05	A2a-adenosinrezeptorantagonisten
TW200621753A (en)	2006-07-01	Pyrimidinylimidazoles and methods of making and using the same
MY142804A (en)	2011-01-14	Nk1 antagonists
DE60322103D1 (de)	2008-08-21	Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
EA200400399A1 (ru)	2004-08-26	Способы лечения легочных заболеваний
DE60133421D1 (de)	2008-05-08	Inositolphosphoglycanderivate und ihre medizinische verwendung
EA200400822A1 (ru)	2004-12-30	Производные 3,4-дигидро-1h-изохинолин-2-ила
DE60301261D1 (de)	2005-09-15	Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist
ATE279923T1 (de)	2004-11-15	Urotensin-ii rezeptorantagonisten
BR0114911A (pt)	2003-10-14	4,5-diidro-1,2,4-triazin-3-onas substituìdas, 1,2,4-triazin-3-onas e o seu uso como fungicidas e inseticidas
DE60133137D1 (de)	2008-04-17	Inositolphosphoglycanderivate und ihre medizinische verwendung
TR200001080T2 (tr)	2001-01-22	2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
AP2002002401A0 (en)	2002-03-31	Histamine receptor antagonists.

Legal Events

Date	Code	Title	Description
2008-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties